Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat obesity, in the country. Last summer, the company withdrew the Allurion Balloon from the French market amid concerns about the safety of the weight loss device. The greenlight to relaunch the product is good news for Allurion given that France represents a sizeable portion of its market. Read More
With rates of preeclampsia skyrocketing, the U.S. FDA’s510(k) clearance of Roche Holding AG’s Elecsys test for preeclampsia offers some hope of reducing the number of women and infants who die or experience life-long consequences from the development of dangerously high blood pressure during late pregnancy and in the days immediately following delivery. Read More
Harrison.ai raised AU$179 million (US$112 million) in a series C round to expand its radiology and pathology solutions across the U.S., Europe, the Middle East, Africa and Asia Pacific. Read More
Shanghai Microport Medbot (Group) Co. Ltd. won China National Medical Products Administration approval of its self-developed Toumai single-arm and single-port laparoscopic surgical robot. Read More
The U.S. Court of Appeals for the Federal Circuit occasionally remands a patent litigation case to district court for a variety of reasons, as seen in a decision involving Trudell Medical and D R Burton. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Creative Medical, Veracyte, Volta Medical
. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: CDISC, Delcath Systems, Genomoncology, Jedmed, Lindus Health, Neuralcure, Otologic Technologies, Outset Medical, Pillar Biosciences, Sinocare, Tiger BioSciences. Read More
